Skip to main content

Regulus Therapeutics(RGLS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Regulus Therapeutics

4224 CAMPUS POINT COURT SUITE 210
SAN DIEGO CA 92121 USA
P: 858-202-6300
http://www.regulusrx.com

Profile

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.

Key Executives

NameTitle
Joseph P. HaganCEO/Director
Preston KlassenDirector/Other Corporate Officer/President
Christopher AkerGeneral Counsel/Senior VP
Crispina CalsadaCFO